K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 730.00
-5.00 (-0.68%)
Aug 6, 2026, 12:48 PM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 8.54 billion as of August 5, 2026. Its market cap has increased by 1.54% in one year.
Market Cap
8.54B
Enterprise Value
7.48B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
730.00
ChartMarket Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 8.54B, a decrease of -21.96%. That is a compound annual growth rate of -8.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 8.54B | 11.54% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stella Pharma | 11.35B |
| Kubota Pharmaceutical Holdings | 9.65B |
| CellSeed | 9.04B |
| Immuno-Biological Laboratories | 8.94B |
| Nano Holdings | 8.35B |
| OncoTherapy Science | 8.16B |
| Kidswell Bio | 7.45B |
| StemCell Institute | 7.35B |